MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses.
作者信息
Shivarov Velizar, Dolnik Anna, Lang Katharina M, Krönke Jan, Kuchenbauer Florian, Paschka Peter, Gaidzik Verena I, Döhner Hartmut, Schlenk Richard F, Döhner Konstanze, Bullinger Lars
机构信息
Laboratory of Clinical Immunology, Sofiamed University Hospital, Sofia, Bulgaria.
Department of Internal Medicine III, University Hospital of Ulm, Germany.
出版信息
Haematologica. 2016 Nov;101(11):e454-e456. doi: 10.3324/haematol.2016.146555. Epub 2016 Jul 28.
Abstract
摘要
相似文献
1
MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses.
Haematologica. 2016 Nov;101(11):e454-e456. doi: 10.3324/haematol.2016.146555. Epub 2016 Jul 28.
2
Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
Leukemia. 2013 Mar;27(3):595-603. doi: 10.1038/leu.2012.278. Epub 2012 Oct 1.
3
MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia.
Leukemia. 2016 Mar;30(3):742-6. doi: 10.1038/leu.2015.160. Epub 2015 Jun 25.
4
Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management.
Br J Haematol. 2013 Feb;160(3):303-20. doi: 10.1111/bjh.12135. Epub 2012 Dec 13.
5
[The Cutting-edge of Medicine; Genetic alterations and their prognostic implications in acute myeloid leukemia].
Nihon Naika Gakkai Zasshi. 2015 Jun 10;104(6):1180-8. doi: 10.2169/naika.104.1180.
6
Epigenetic regulation of miRNA genes in acute leukemia.
Leukemia. 2012 Mar;26(3):395-403. doi: 10.1038/leu.2011.344. Epub 2011 Dec 6.
7
A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients.
Leukemia. 2015 May;29(5):1051-9. doi: 10.1038/leu.2014.333. Epub 2014 Nov 27.
8
MicroRNA let-7f is down-regulated in patients with refractory acute myeloid leukemia and is involved in chemotherapy resistance of adriamycin-resistant leukemic cells.
Leuk Lymphoma. 2014 Jul;55(7):1645-8. doi: 10.3109/10428194.2013.847936. Epub 2013 Nov 12.
9
High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
Oncotarget. 2015 Mar 10;6(7):5299-309. doi: 10.18632/oncotarget.3024.
10
Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia.
Leuk Res. 2013 Dec;37(12):1642-7. doi: 10.1016/j.leukres.2013.09.022. Epub 2013 Sep 30.
引用本文的文献
1
The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation.
Leukemia. 2025 May;39(5):1090-1101. doi: 10.1038/s41375-025-02558-x. Epub 2025 Mar 17.
2
A Novel Two-Gene Expression-Based Prognostic Score in Malignant Pleural Mesothelioma.
Diagnostics (Basel). 2023 Apr 26;13(9):1556. doi: 10.3390/diagnostics13091556.
3
Analyses of Transcriptomics Cell Signalling for Pre-Screening Applications in the Integrated Approach for Testing and Assessment of Non-Genotoxic Carcinogens.
Int J Mol Sci. 2022 Oct 22;23(21):12718. doi: 10.3390/ijms232112718.
4
The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells.
Int J Mol Sci. 2020 Apr 21;21(8):2907. doi: 10.3390/ijms21082907.
5
High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia.
Cancer Cell Int. 2019 May 7;19:122. doi: 10.1186/s12935-019-0843-9. eCollection 2019.
6
Gene expression patterns as predictive biomarkers in hematology-oncology: principal hurdles on the road to the clinic.
Haematologica. 2017 Jan;102(1):e31-e32. doi: 10.3324/haematol.2016.157065.
本文引用的文献
1
A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients.
Leukemia. 2015 May;29(5):1051-9. doi: 10.1038/leu.2014.333. Epub 2014 Nov 27.
2
Expression profiling of leukemia patients: key lessons and future directions.
Exp Hematol. 2014 Aug;42(8):651-60. doi: 10.1016/j.exphem.2014.04.006. Epub 2014 Apr 15.
3
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia.
Leukemia. 2014 Apr;28(4):804-12. doi: 10.1038/leu.2013.281. Epub 2013 Sep 27.
4
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms.
Blood. 2013 Aug 8;122(6):999-1006. doi: 10.1182/blood-2013-01-480970. Epub 2013 Jun 17.
5
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
N Engl J Med. 2013 May 30;368(22):2059-74. doi: 10.1056/NEJMoa1301689. Epub 2013 May 1.
6
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
Blood. 2012 Nov 1;120(18):e83-92. doi: 10.1182/blood-2011-12-401471. Epub 2012 Sep 13.
7
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders.
Leukemia. 2012 Dec;26(12):2447-54. doi: 10.1038/leu.2012.130. Epub 2012 May 15.
8
Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia.
Haematologica. 2011 Dec;96(12):1783-91. doi: 10.3324/haematol.2011.046888. Epub 2011 Aug 31.
9
MicroRNAs in acute leukemia: from biological players to clinical contributors.
Leukemia. 2012 Jan;26(1):1-12. doi: 10.1038/leu.2011.151. Epub 2011 Jun 24.
10
The prognostic and functional role of microRNAs in acute myeloid leukemia.
Blood. 2011 Jan 27;117(4):1121-9. doi: 10.1182/blood-2010-09-191312. Epub 2010 Nov 2.
Zotero 插件